New England Capital Financial Advisors LLC
Source: SEC Form 13F · as of Mar 2026New England Capital Financial Advisors LLC holds 31 biotech & pharma companies tracked by BioSniper, totaling $2.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
31
Total value held
$2.4M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 2,351 | $575K |
| BMYBRISTOL MYERS SQUIBB CO | 6,394 | $388K |
| MRKMerck & Co., Inc. | 2,182 | $262K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 927 | $251K |
| PFEPFIZER INC | 5,726 | $161K |
| ELVElevance Health Inc. | 547 | $160K |
| PMPhilip Morris International Inc | 815 | $135K |
| AZNASTRAZENECA PLC | 560 | $110K |
| ABBVAbbVie Inc. | 363 | $79K |
| DGXQuest Diagnostics Incorporated | 312 | $61K |
| GILDGILEAD SCIENCES, INC. | 389 | $54K |
| ABTABBOTT LABORATORIES | 462 | $47K |
| LLYELI LILLY & Co | 34 | $32K |
| SRPTSarepta Therapeutics, Inc. | 1,100 | $24K |
| ZBHZimmer Biomet Holdings Inc. | 220 | $20K |
| NVSNovartis AG | 91 | $14K |
| BAXBaxter International Inc. | 706 | $12K |
| VTRSViatris Inc | 825 | $11K |
| BHVNBiohaven Ltd. | 1,000 | $8K |
| GEHCGE HealthCare Technologies Inc. | 78 | $6K |
| ZTSZoetis Inc. | 25 | $3K |
| CMPSCOMPASS Pathways plc | 300 | $2K |
| VRCAVerrica Pharmaceuticals Inc. | 200 | $1K |
| OGNOrganon & Co. | 161 | $966 |
| HURATuHURA Biosciences, Inc./NV | 281 | $503 |
| HRTXHERON THERAPEUTICS, INC. /DE/ | 475 | $381 |
| ARRYARRAY BIOPHARMA INC | 39 | $280 |
| SCLXSCILEX HOLDING CO | 23 | $154 |
| MREOMereo BioPharma Group plc | 300 | $99 |
| AVNSAvanos Medical Inc. | 6 | $85 |
| CGCCanopy Growth Corp | 10 | $10 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.